科美诊断
(688468)
| 流通市值：25.59亿 | | | 总市值：25.59亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 154,462,229.88 | 73,346,975.09 | 332,678,626.15 | 260,821,861.59 |
| 营业收入 | 154,462,229.88 | 73,346,975.09 | 332,678,626.15 | 260,821,861.59 |
| 二、营业总成本 | 141,780,098.79 | 65,406,414.51 | 291,826,607.56 | 223,690,330.27 |
| 营业成本 | 61,502,769.65 | 28,251,884.48 | 111,520,648.88 | 83,409,802.03 |
| 税金及附加 | 2,472,450.77 | 1,192,067.23 | 5,333,853.25 | 4,145,065.88 |
| 销售费用 | 22,793,712.88 | 9,957,192.47 | 60,575,790.34 | 48,904,330.59 |
| 管理费用 | 21,595,628.66 | 10,451,381.88 | 44,466,283.66 | 32,733,615.89 |
| 研发费用 | 36,629,004.26 | 17,060,876.14 | 73,310,422.51 | 56,428,488.49 |
| 财务费用 | -3,213,467.43 | -1,506,987.69 | -3,380,391.08 | -1,930,972.61 |
| 其中:利息费用 | 2,844,507.99 | 1,421,779.58 | 6,408,319.57 | 4,938,687.86 |
| 其中:利息收入 | 6,229,730.78 | 3,016,512.87 | 9,963,817.81 | 7,056,416.86 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 306,684.16 | -676,472.6 | 1,222,390.4 | - |
| 加:投资收益 | 2,361,821.01 | 1,649,387.71 | 8,842,921.04 | 8,354,979.98 |
| 资产处置收益 | 664,578.3 | 386,751.41 | 118,694.97 | 108,923.99 |
| 资产减值损失(新) | -1,877,315.67 | 582,624.98 | -9,758,207.52 | -4,520,051.07 |
| 信用减值损失(新) | 186,965.64 | 316,856.35 | -630,526.83 | -876.31 |
| 其他收益 | 4,145,059.89 | 369,747.11 | 9,078,915.83 | 4,908,948.17 |
| 四、营业利润 | 18,469,924.42 | 10,569,455.54 | 49,726,206.48 | 45,983,456.08 |
| 加:营业外收入 | 754.7 | 674.61 | 278,119.67 | 355,415.77 |
| 减:营业外支出 | 26,328.44 | 2,817.96 | 185,748.38 | 183,211.39 |
| 五、利润总额 | 18,444,350.68 | 10,567,312.19 | 49,818,577.77 | 46,155,660.46 |
| 减:所得税费用 | 2,908,190.99 | 1,606,419.34 | 5,906,059.21 | 4,592,884.44 |
| 六、净利润 | 15,536,159.69 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 15,536,159.69 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 15,536,159.69 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 |
| 扣除非经常损益后的净利润 | 9,566,055.4 | 7,594,485.61 | 26,572,639.79 | 30,523,337.53 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.04 | 0.02 | 0.11 | 0.1 |
| (二)稀释每股收益 | 0.04 | 0.02 | 0.11 | 0.1 |
| 九、综合收益总额 | 15,536,159.69 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 |
| 归属于母公司股东的综合收益总额 | 15,536,159.69 | 8,960,892.85 | 43,912,518.56 | 41,562,776.02 |
| 公告日期 | 2026-08-28 | 2026-04-29 | 2026-04-29 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |